Fine-Scale Histologic Features Estimated at Low Magnification
By LabMedica International staff writers Posted on 03 Jul 2018 |

Image: The Aperio Scanscope XT whole-slide scanner (Photo courtesy of Leica Microsystems).
Whole-slide imaging has ushered in a new era of technology that has fostered the use of computational image analysis for diagnostic support and has begun to transfer the act of analyzing a slide to computer monitors.
Due to the overwhelming amount of detail available in whole-slide images, analytic procedures, whether computational or visual, often operate at magnifications lower than the magnification at which the image was acquired and as a result, a corresponding reduction in image resolution occurs.
A team of scientists led by those at Drexel University College of Medicine (Philadelphia, PA, USA) examined the correspondence between the color and spatial properties of whole-slide images to elucidate the impact of resolution reduction on the histologic attributes of the slide. They simulated image resolution reduction and modeled its effect on classification of the underlying histologic structure. By harnessing measured histologic features and the intrinsic spatial relationships between histologic structures, they developed a predictive model to estimate the histologic composition of tissue in a manner that exceeds the resolution of the image.
The scientists acquired high-resolution (0.25 µm/pixel) digital images of H&E-stained slides from 88 excised breast specimens at ×40 magnification using the Aperio Scanscope XT whole-slide scanner. For each whole-slide image, they selected two regions of interest (ROIs) for analysis, each 800 µm × 800 µm in size, with an effort made to capture epithelium and stroma. To estimate histologic composition from low-magnification images, they developed a model that uses the color of a pixel to surmise its content. By exploiting the spatial relationships between histologic elements, and measuring their individual color properties, they derived axes in hue-saturation-value (HSV) space that can be used to predict the histologic composition of a pixel.
The team analyzed 79 images acquired at ×40 magnification using whole-slide imaging. Images were stored in a proprietary format that enabled direct access to the image at lower resolutions, thereby reducing bandwidth and facilitating rapid loading for viewing and analysis. The investigators reported that reduction in resolution resulted in a significant loss of the ability to accurately characterize histologic components at magnifications less than ×10, but by utilizing pixel color, this ability was improved at all magnifications.
The authors concluded that multiscale analysis of histologic images requires an adequate understanding of the limitations imposed by image resolution and their findings suggest that some of these limitations may be overcome with computational modeling. The study was published on June 18, 2018, in the journal Archives Of Pathology & Laboratory Medicine.
Related Links:
Drexel University College of Medicine
Due to the overwhelming amount of detail available in whole-slide images, analytic procedures, whether computational or visual, often operate at magnifications lower than the magnification at which the image was acquired and as a result, a corresponding reduction in image resolution occurs.
A team of scientists led by those at Drexel University College of Medicine (Philadelphia, PA, USA) examined the correspondence between the color and spatial properties of whole-slide images to elucidate the impact of resolution reduction on the histologic attributes of the slide. They simulated image resolution reduction and modeled its effect on classification of the underlying histologic structure. By harnessing measured histologic features and the intrinsic spatial relationships between histologic structures, they developed a predictive model to estimate the histologic composition of tissue in a manner that exceeds the resolution of the image.
The scientists acquired high-resolution (0.25 µm/pixel) digital images of H&E-stained slides from 88 excised breast specimens at ×40 magnification using the Aperio Scanscope XT whole-slide scanner. For each whole-slide image, they selected two regions of interest (ROIs) for analysis, each 800 µm × 800 µm in size, with an effort made to capture epithelium and stroma. To estimate histologic composition from low-magnification images, they developed a model that uses the color of a pixel to surmise its content. By exploiting the spatial relationships between histologic elements, and measuring their individual color properties, they derived axes in hue-saturation-value (HSV) space that can be used to predict the histologic composition of a pixel.
The team analyzed 79 images acquired at ×40 magnification using whole-slide imaging. Images were stored in a proprietary format that enabled direct access to the image at lower resolutions, thereby reducing bandwidth and facilitating rapid loading for viewing and analysis. The investigators reported that reduction in resolution resulted in a significant loss of the ability to accurately characterize histologic components at magnifications less than ×10, but by utilizing pixel color, this ability was improved at all magnifications.
The authors concluded that multiscale analysis of histologic images requires an adequate understanding of the limitations imposed by image resolution and their findings suggest that some of these limitations may be overcome with computational modeling. The study was published on June 18, 2018, in the journal Archives Of Pathology & Laboratory Medicine.
Related Links:
Drexel University College of Medicine
Latest Pathology News
- Novel UV and Machine Learning-Aided Method Detects Microbial Contamination in Cell Cultures
- New Error-Corrected Method to Help Detect Cancer from Blood Samples Alone
- "Metal Detector" Algorithm Hunts Down Vulnerable Tumors
- Novel Technique Uses ‘Sugar’ Signatures to Identify and Classify Pancreatic Cancer Cell Subtypes
- Advanced Imaging Reveals Mechanisms Causing Autoimmune Disease
- AI Model Effectively Predicts Patient Outcomes in Common Lung Cancer Type
- AI Model Predicts Patient Response to Bladder Cancer Treatment
- New Laser-Based Method to Accelerate Cancer Diagnosis
- New AI Model Predicts Gene Variants’ Effects on Specific Diseases
- Powerful AI Tool Diagnoses Coeliac Disease from Biopsy Images with Over 97% Accuracy
- Pre-Analytical Conditions Influence Cell-Free MicroRNA Stability in Blood Plasma Samples
- 3D Cell Culture System Could Revolutionize Cancer Diagnostics
- Painless Technique Measures Glucose Concentrations in Solution and Tissue Via Sound Waves
- Skin-Based Test to Improve Diagnosis of Rare, Debilitating Neurodegenerative Disease
- Serum Uromodulin Could Indicate Acute Kidney Injury in COVID-19 Patients
- AI Model Reveals True Biological Age From Five Drops of Blood
Channels
Clinical Chemistry
view channel
‘Brilliantly Luminous’ Nanoscale Chemical Tool to Improve Disease Detection
Thousands of commercially available glowing molecules known as fluorophores are commonly used in medical imaging, disease detection, biomarker tagging, and chemical analysis. They are also integral in... Read more
Low-Cost Portable Screening Test to Transform Kidney Disease Detection
Millions of individuals suffer from kidney disease, which often remains undiagnosed until it has reached a critical stage. This silent epidemic not only diminishes the quality of life for those affected... Read more
New Method Uses Pulsed Infrared Light to Find Cancer's 'Fingerprints' In Blood Plasma
Cancer diagnoses have traditionally relied on invasive or time-consuming procedures like tissue biopsies. Now, new research published in ACS Central Science introduces a method that utilizes pulsed infrared... Read moreMolecular Diagnostics
view channel
Blood Biomarker Test Could Detect Genetic Predisposition to Alzheimer’s
New medications for Alzheimer’s disease, the most common form of dementia, are now becoming available. These treatments, known as “amyloid antibodies,” work by promoting the removal of small deposits from... Read more
Novel Autoantibody Against DAGLA Discovered in Cerebellitis
Autoimmune cerebellar ataxias are strongly disabling disorders characterized by an impaired ability to coordinate muscle movement. Cerebellar autoantibodies serve as useful biomarkers to support rapid... Read more
Gene-Based Blood Test Accurately Predicts Tumor Recurrence of Advanced Skin Cancer
Melanoma, an aggressive form of skin cancer, becomes extremely difficult to treat once it spreads to other parts of the body. For patients with metastatic melanoma tumors that cannot be surgically removed... Read moreHematology
view channel
New Scoring System Predicts Risk of Developing Cancer from Common Blood Disorder
Clonal cytopenia of undetermined significance (CCUS) is a blood disorder commonly found in older adults, characterized by mutations in blood cells and a low blood count, but without any obvious cause or... Read more
Non-Invasive Prenatal Test for Fetal RhD Status Demonstrates 100% Accuracy
In the United States, approximately 15% of pregnant individuals are RhD-negative. However, in about 40% of these cases, the fetus is also RhD-negative, making the administration of RhoGAM unnecessary.... Read moreImmunology
view channel
Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer
Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more
Machine Learning-Enabled Blood Test Predicts Immunotherapy Response in Lymphoma Patients
Chimeric antigen receptor (CAR) T-cell therapy has emerged as one of the most promising recent developments in the treatment of blood cancers. However, over half of non-Hodgkin lymphoma (NHL) patients... Read moreMicrobiology
view channel
Handheld Device Delivers Low-Cost TB Results in Less Than One Hour
Tuberculosis (TB) remains the deadliest infectious disease globally, affecting an estimated 10 million people annually. In 2021, about 4.2 million TB cases went undiagnosed or unreported, mainly due to... Read more
New AI-Based Method Improves Diagnosis of Drug-Resistant Infections
Drug-resistant infections, particularly those caused by deadly bacteria like tuberculosis and staphylococcus, are rapidly emerging as a global health emergency. These infections are more difficult to treat,... Read more
Breakthrough Diagnostic Technology Identifies Bacterial Infections with Almost 100% Accuracy within Three Hours
Rapid and precise identification of pathogenic microbes in patient samples is essential for the effective treatment of acute infectious diseases, such as sepsis. The fluorescence in situ hybridization... Read moreTechnology
view channel
Disposable Microchip Technology Could Selectively Detect HIV in Whole Blood Samples
As of the end of 2023, approximately 40 million people globally were living with HIV, and around 630,000 individuals died from AIDS-related illnesses that same year. Despite a substantial decline in deaths... Read more
Pain-On-A-Chip Microfluidic Device Determines Types of Chronic Pain from Blood Samples
Chronic pain is a widespread condition that remains difficult to manage, and existing clinical methods for its treatment rely largely on self-reporting, which can be subjective and especially problematic... Read more
Innovative, Label-Free Ratiometric Fluorosensor Enables More Sensitive Viral RNA Detection
Viruses present a major global health risk, as demonstrated by recent pandemics, making early detection and identification essential for preventing new outbreaks. While traditional detection methods are... Read moreIndustry
view channel
Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions
Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Grifols and Tecan’s IBL Collaborate on Advanced Biomarker Panels
Grifols (Barcelona, Spain), one of the world’s leading producers of plasma-derived medicines and innovative diagnostic solutions, is expanding its offer in clinical diagnostics through a strategic partnership... Read more